Epoprostenol Exposure During Pregnancy

Institutional policies restricting pregnant providers from caring for patients receiving inhaled epoprostenol exist across the nation based on little to no data to substantiate this practice. Over the last 2 decades, the use of inhaled pulmonary vasodilators has expanded in patients with cardiac and...

Full description

Bibliographic Details
Main Authors: Emily E. Naoum, MD, Carolyn LaVita, MHA, RRT, Natasha Lopez, PharmD, BCCCP, Alexa Nardone, PharmD, BCCCP, Marti D. Soffer, MD, MPH, Kenneth T. Shelton, MD
Format: Article
Language:English
Published: Wolters Kluwer 2023-06-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000928

Similar Items